| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.47 | 0.006 |